Chelsea Therapeutics Announces Reorganization Plan to Boost Stock Value

More news came out of Charlotte, N.C., Tuesday morning when beleaguered Chelsea Therapeutics (CHTP) announced its plans to undergo a complete reorganization of the company, which is to include layoffs, a new executive structure and changes to the Board of Directors, all with the long-term goal of developing more stockholder value, according to a press release.

The layoffs are expected to save the company $3.5 million in salaries over a year, and the layoffs should be completed by the end of the third quarter of 2012. Part of the plan includes not accepting any more patients for the company’s trial of the hypertension drug Northera, which should then produce results by the end of the year.

In other news, company founder, CEO and President Dr. Simon Pedder, announced that he was stepping down from the company effective immediately, and will serve only in an advisory capacity. The same is said for Keith Schmidt, vice president for marketing and sales, who is resigning his post but will remain an advisor to the company. During the search for a new CEO, Joseph G. Oliveto, VP for Operations for the last four years, will serve as interim CEO. In addition, three members of the Board of Directors (including Chairman Kevan Clemens) are stepping down.

While Chelsea is not widely held by hedge funds, this news may be very uncertain for Julian and Felix Baker’s Baker Bros. Advisors, which was invested nearly $5.9 million in Chelsea at the end of March. The next seven hedge funds combined were invested a total of less than $1 million.

“Chelsea Therapeutics has faced tremendous challenges in moving Northera forward through the regulatory process, making these difficult decisions necessary to ensure stockholder value is preserved in the short term and can be built over the long-term,” said Dr. Michael Weiser, the new Chairman of the Board in the wake of Clemens’ resignation, in a press release. ”We believe that this reorganization should allow the Company’s resources and capital to be laser-focused on efficient conclusion of the 306B study and the evaluation of next steps in the regulatory process. In tandem, the Board plans to explore and evaluate all available strategic options to determine the best path forward in the long-term strategic interests of the Company and its stockholders. We remain committed to Northera, a treatment which meets an important unmet need in patients and has a significant record of efficacy and safety in the clinic and in ex-U.S. markets. We would like to thank those employees leaving the Company for their service. We would also like to recognize Dr. Pedder’s years of dedication to Chelsea and his work in helping to advance the Company’s innovative therapies.”

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

The 10 Biggest Airports in the World

The 5 Most Gang Infested Cities In America

The 34 Smartest Countries in the World

The 10 Countries with the Highest Suicide Rates

The 10 Most Technologically Advanced Countries in the World

The 10 Safest Countries in the World to Live in Peace

The 10 Top Selling Smartphones in the World 2014

The 12 Biggest Shopping Centers in the World

The 10 Friendliest Countries in the World

Qihoo 360 Technology Co Ltd (QIHU), Actavis plc (ACT), Yahoo! Inc. (YHOO) Among 20 Long Ideas from Sohn Canada

The 10 Laziest Countries in the World

The 10 Most Polluted Countries in the World

The 10 Most Dangerous Cities in America 2014

The Top 10 Gold Producing Countries in the World

The 10 Tallest Buildings in the World

The 10 Richest Stand Up Comedians in the World

The 10 Fattest Countries in the World

The 5 Best Summer Jobs for Teens

The 10 Most Religious Countries in the World Keeping the Faith

The 10 Most Educated Countries in the World

The 10 Most Popular Cell Phones in the World

The 10 Drunkest Countries in the World

The 10 Most Expensive Private Schools in the World

The 10 Smallest Countries in the World

Walking Dead Season 5 Spoilers You’ll Wish You Didn’t Know

The 10 Poorest Countries in the World

The 10 Greenest Countries in the World

The Top 10 Countries with the Highest Population in the World

The 10 Most Visited Countries in the World

The Top 10 Star Wars Characters in the Iconic Series

The 10 Most Expensive Android Phones in the World

5 Reasons Why The Illuminati Is Real and a Threat to Society

The 6 Scariest Halloween Costumes Ever Screamed At

The 4 Biggest Hedge Fund Managers in the World Today

The 15 Most Densely Populated Countries in the World

The 10 Biggest Tea Drinking Countries in the World

Top 6 Ways to Improve Your Checkout Process and Close Sales

The 5 Most Profitable Online Businesses You Can Start Today

The 20 Most Profitable Hospitals in the US

The 5 Most Profitable Home Businesses to Start

The 7 Teams that Will Win the Stanley Cup in 2015

The Top 10 Most Expensive Digital Cameras to Snap Stunning Shots With

The 10 Highest Quality Fast Food Restaurants In America Today

The 8 Best Halloween Decorating Ideas to Spook Up Your House

10 Marvel Women that Should Get a Movie Right Now

The 20 Best Remixes of Popular Songs that Will Make You Forget the Originals

7 Most Expensive Cities in the World

5 Least Expensive Cities in the World

10 Celebrities Who Believe In Scientology

10 High Margin Food Products to Build a Business Around

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!